DUBLIN, Ireland - Trinity Biotech plc (NASDAQ:TRIB), a leading provider of diagnostic solutions for the healthcare industry, ...
Trinity Biotech has announced that it received early approval from the World Health Organization to commence offshore manufacturing of its rapid HIV tests, TrinScreen HIV and Uni-Gold HIV.
Trinity Biotech ( ($TRIB) ) has issued an announcement. Trinity Biotech announced a positive update regarding the U.S. government’s funding for ...
Trinscreen HIV by Trinity Biotech Manufacturing, Determine HIV-1/2 (Abbott Diagnostics Medical Co.Ltd), Insti HIV-1/HIV-2 Antibody Test that is manufactured by BioLytical Laboratories Inc. Others ...
Trinity Biotech has received earlier than expected approval from the World Health Organization (WHO) to permit the later-stage manufacturing process of TrinScreen HIV and Uni-Gold HIV at its ...
enhancing the company's operational capabilities and market position following a recent WHO approval for more cost-effective manufacturing of HIV testing products. Trinity Biotech has secured ...
Trinity Biotech has received earlier than expected approval from the World Health Organization (WHO) to permit the later-stage manufacturing process of TrinScreen HIV and Uni-Gold HIV at its ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results